Search Within

Lauren Rhea Schaff

  1. "Christian Grommes"
Formats
  1. Meeting Abstract (19)
  2. Journal Article (14)
  3. Review (5)
  4. Correspondence (1)
Groups
  1. Tow Center for Developmental Oncology (TCDO) (21)
  2. GSK Faculty (18)
  3. Human Oncology and Pathogenesis Program (18)
  4. Epidemiology and Biostatistics (13)
  5. Neuroradiology Service (13)
  6. Radiology, Department of (13)

More Groups

People
  1. Christian Grommes (39)
  2. Igor Gavrilovic (16)
  3. Ingo Mellinghoff (16)
  4. Elena Pentsova (14)
  5. Lisa De Angelis (14)
  6. Andrew Lin (12)

More People

Years
  1. 2025 (5)
  2. 2024 (6)
  3. 2023 (5)
  4. 2022 (8)
  5. 2021 (5)
  6. 2020 (6)

More Years

Publications
  1. Neuro-Oncology (12)
  2. Blood (6)
  3. Journal of Clinical Oncology (3)
  4. Neurology (3)
  5. Annals of Lymphoma (2)
  6. International Journal of Radiation Oncology, Biology, Physics (2)

More Publications

Publishers
  1. Oxford University Press (12)
  2. American Society of Hematology (6)
  3. American Society of Clinical Oncology (5)
  4. Lippincott Williams & Wilkins (4)
  5. Springer (3)
  6. AME Publishing Company (2)

More Publishers

Results (39)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prospective characterization of germline variants in patients with gliomas and glioneuronal tumors
    Journal Article

    Nandakumar, S.; Mehine, M.; Kemel, Y.; Bandlamudi, C.; Mandelker, D.; Rosenblum, M. K.; Bale, T.; Karajannis, M. A.; Sait, S. F.; Elmore, K. B.; more...
    Acta Neuropathologica (2025)

    Fulltext@MSK | Save
  • Phase Ib study with expansion of ibrutinib, lenalidomide, and rituximab in patients with relapsed/refractory central nervous system lymphoma
    Journal Article

    Schaff, L. R.; Piotrowski, A. F.; Pentsova, E.; Gavrilovic, I. T.; Lin, A.; Kaley, T. J.; Wongchai, V.; Emadi-Paramkouhi, L.; Madzsar, J.; Quinn, L.; more...
    Neuro-Oncology (2025)

    Fulltext@MSK | Save
  • Tirabrutinib for the treatment of relapsed or refractory primary central nervous system lymphoma: Efficacy and safety from the phase II PROSPECT study
    Meeting Abstract

    Nayak, L.; Grommes, C.; Kallam, A.; Peereboom, D. M.; Ambady, P.; Mendez, J. S.; Aregawi, D. G.; Sumrall, A. L.; Omuro, A. M. P.; Iwamoto, F.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Reply to: Safe outpatient treatment of CNS lymphoma achieved by using glucarpidase after high-dose methotrexate
    Correspondence

    Schaff, L. R.; Grommes, C.
    JCO Oncology Practice (2025)

    Fulltext@MSK | Save
  • Consolidation regimen and cerebral atrophy in patients with primary central nervous system lymphoma
    Journal Article

    Tringale, K. R.; Grommes, C.; Ucpinar, B. A.; Reiner, A. S.; Yahalom, J.; Cederquist, G. Y.; Schaff, L. R.; Hatzoglou, V.; Young, R. J.; Payinkay, M.; more...
    International Journal of Radiation Oncology, Biology, Physics (2025)

    Fulltext@MSK | Save
  • Prospective germline sequencing of patients with gliomas, glioneuronal or neuronal tumors
    Meeting Abstract

    Lin, A.; Nandakumar, S.; Mehine, M.; Kemel, Y.; Mandelker, D.; Karajannis, M.; Sait, S. F.; Gavrilovic, I.; Pentsova, E.; Schaff, L.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • The association of consolidation strategies with cerebral atrophy in primary central nervous system lymphoma (PCNSL)
    Meeting Abstract

    Tringale, K. R.; Grommes, C.; Ucpinar, B. A.; Reiner, A.; Yahalom, J.; Cederquist, G.; Schaff, L.; Young, R. J.; Hatzoglou, V.; Payinkay, M.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Outcomes and relapse patterns in primary central nervous system lymphoma: Longitudinal analysis of 559 patients diagnosed from 1983 to 2020
    Journal Article

    Tringale, K. R.; Scordo, M.; Yahalom, J.; White, C.; Zhang, Z.; Vachha, B.; Cederquist, G.; Schaff, L.; Deangelis, L.; Grommes, C.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Low-dose planned glucarpidase allows safe outpatient high-dose methotrexate treatment for CNS lymphoma
    Journal Article

    Schaff, L. R.; Carlow, D.; Schofield, R.; Wongchai, V.; Madzsar, J.; Hyde, A.; Reiner, A. S.; Panageas, K. S.; DeAngelis, L. M.; Mellinghoff, I. K.; more...
    JCO Oncology Practice (2024)

    Fulltext@MSK | Save
  • A phase II study assessing long-term response to ibrutinib monotherapy in recurrent or refractory CNS lymphoma
    Journal Article

    Grommes, C.; Nandakumar, S.; Schaff, L. R.; Gavrilovic, I.; Kaley, T. J.; Nolan, C. P.; Stone, J.; Thomas, A. A.; Tang, S. S.; Wolfe, J.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save